3-n-methylspiperone has been researched along with pramipexole in 1 studies
| Studies (3-n-methylspiperone) | Trials (3-n-methylspiperone) | Recent Studies (post-2010) (3-n-methylspiperone) | Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) |
|---|---|---|---|---|---|
| 155 | 6 | 7 | 1,103 | 219 | 517 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Jiang, C; Keck, TM; Levant, B; Newman, AH; Wang, S | 1 |
1 other study(ies) available for 3-n-methylspiperone and pramipexole
| Article | Year |
|---|---|
Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists.
Topics: Animals; Arrestins; beta-Arrestins; Cell Line; Cyclobutanes; Humans; Male; Naphthalenes; Radioligand Assay; Rats, Sprague-Dawley; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship; Tranylcypromine | 2014 |